These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30211932)

  • 1. Optimal drug-eluting stent implantation with the aid of optical coherence tomography in the stenotic lesion of ectatic coronary artery.
    Kim Y; Jeong MH; Kim MC; Sim DS; Hong YJ; Kim JH; Ahn Y
    Cardiol J; 2018; 25(4):534-535. PubMed ID: 30211932
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent.
    Schneider VS; Skurk C; Riedel M; Abdelwahed YS; Landmesser U; Leistner DM
    Clin Res Cardiol; 2017 Jul; 106(7):557-559. PubMed ID: 28374059
    [No Abstract]   [Full Text] [Related]  

  • 3. Rendered OCT Imaging of an Impressive Stent Malapposition in the Left Main Coronary Artery.
    Merella P; Lorenzoni G; Viola G; Berne P; Casu G
    J Invasive Cardiol; 2019 Sep; 31(9):E280-E281. PubMed ID: 31478900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of stent positioning on coronary blood flow after primary percutaneous coronary intervention.
    Kranjec I; Cercek M
    Int J Cardiol; 2016 Jan; 203():134-5. PubMed ID: 26512826
    [No Abstract]   [Full Text] [Related]  

  • 5. Bifurcation and ostial optical coherence tomography mapping (BOOM) - Case description of a novel bifurcation stent technique.
    Shlofmitz E; Sosa F; Goldberg A; Maehara A; Ali ZA; Mintz GS; Moses JW; Stone GW; Shlofmitz RA; Jeremias A
    Cardiovasc Revasc Med; 2018 Dec; 19(8S):47-49. PubMed ID: 29779971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-dilatation after implantation of bioresorbable everolimus- and novolimus-eluting scaffolds: an observational optical coherence tomography study of acute mechanical effects.
    Blachutzik F; Boeder N; Wiebe J; Mattesini A; Dörr O; Most A; Bauer T; Röther J; Tröbs M; Schlundt C; Achenbach S; Hamm CW; Nef HM
    Clin Res Cardiol; 2017 Apr; 106(4):271-279. PubMed ID: 27757522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of optical coherence tomography guided percutaneous coronary intervention to assess stent malapposition in de-novo coronary lesions.
    Ratheesh KJ; Jaitly S; Vijayvergiya R
    Indian Heart J; 2018; 70(2):328-329. PubMed ID: 29716717
    [No Abstract]   [Full Text] [Related]  

  • 8. Rational and design of the European randomized Optical Coherence Tomography Optimized Bifurcation Event Reduction Trial (OCTOBER).
    Holm NR; Andreasen LN; Walsh S; Kajander OA; Witt N; Eek C; Knaapen P; Koltowski L; Gutiérrez-Chico JL; Burzotta F; Kockman J; Ormiston J; Santos-Pardo I; Laanmets P; Mylotte D; Madsen M; Hjort J; Kumsars I; Råmunddal T; Christiansen EH
    Am Heart J; 2018 Nov; 205():97-109. PubMed ID: 30205242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference in vascular response between sirolimus-eluting- and everolimus-eluting stents in ostial left circumflex artery after unprotected left main as observed by optical coherence tomography.
    Fujino Y; Attizzani GF; Tahara S; Naganuma T; Takagi K; Yabushita H; Wang W; Tanaka K; Matsumoto T; Kawamoto H; Yamada Y; Amano S; Watanabe Y; Warisawa T; Sato T; Mitomo S; Kurita N; Ishiguro H; Hozawa K; Tsukahara T; Motosuke M; Bezerra HG; Nakamura S; Nakamura S
    Int J Cardiol; 2017 Mar; 230():284-292. PubMed ID: 28065691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of vascular response after drug-eluting stents implantation in patients with diabetes mellitus: an optical coherence tomography sub-study of the J-DESsERT.
    Kubo T; Akasaka T; Tanimoto T; Takano M; Seino Y; Nasu K; Itoh T; Mizuno K; Okura H; Shinke T; Kotani J; Ito S; Yokoi H; Muramatsu T; Nakamura M; Nanto S
    Heart Vessels; 2016 Apr; 31(4):465-73. PubMed ID: 25630713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unravelment of Medtronic Onyx stent during bifurcation stenting using the jailed wire technique; An adverse effect of helical stent structure?
    Leenders GE; Liew HB; Stella PR
    Cardiovasc Revasc Med; 2018 Dec; 19(8S):58-59. PubMed ID: 30115559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left main coronary artery stenosis due to a protruding calcified nodule.
    Triantafyllis AS; McCutcheon K; Adriaenssens T; Bennett J
    Acta Cardiol; 2018 Apr; 73(2):193-194. PubMed ID: 28730916
    [No Abstract]   [Full Text] [Related]  

  • 13. Serial assessment by optical coherence tomography of early and late vascular responses after implantation of an absorbable-coating Sirolimus-Eluting stent (from the first-in-human DESSOLVE I trial).
    Attizzani GF; Bezerra HG; Ormiston J; Wang W; Donohoe D; Wijns W; Costa MA
    Am J Cardiol; 2013 Nov; 112(10):1557-64. PubMed ID: 23992957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abluminal Neointimal Healing by Optical Coherence Tomography Assessment After Drug-Eluting Stent Implantation on Organized Recanalized Thrombus.
    Camacho Freire SJ; Limpo B; León Jiménez J; Gómez Menchero AE; Roa Garrido J; Cardenal Piris R; Díaz Fernández JF
    J Invasive Cardiol; 2017 Nov; 29(11):E161-E162. PubMed ID: 29086734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-stent accordion phenomenon.
    Nishi T; Hasegawa A; Miyahara H; Nameki M; Kobayashi Y
    Int J Cardiol; 2016 Oct; 220():129-30. PubMed ID: 27376568
    [No Abstract]   [Full Text] [Related]  

  • 16. Healing responses after bifurcation stenting with the dedicated TRYTON Side-Branch Stent™ in combination with XIENCE-V™ stents: a clinical, angiography, fractional flow reserve, and optical coherence tomography study: the PYTON (Prospective evaluation of the TRYTON Side-Branch Stent™ with an additional XIENCE-v™ everolimus-eluting stent in coronary bifurcation lesions) study.
    Dubois C; Adriaenssens T; Ughi G; Wiyono S; Bennett J; Coosemans M; Ferdinande B; Sinnaeve P; D'hooge J; Desmet W
    Catheter Cardiovasc Interv; 2013 Feb; 81(3):E155-64. PubMed ID: 22745031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
    Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
    Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Provisional main branch stenting with drug-eluting stents after drug-eluting balloon treatment of the side branch: a simple and durable technique for treating bifurcation lesions.
    McCutcheon K; Garda R; Mkhwanazi L; Vachiat A; Ramjee R; Moosa J; Tsabedze N; Karolia S; Manga P
    Int J Cardiol; 2015 Mar; 182():294-6. PubMed ID: 25585366
    [No Abstract]   [Full Text] [Related]  

  • 19. Paclitaxel-coated balloon exerts late vessel healing and enlargement: A documented phenomenon with optical coherence tomography analysis.
    Piraino D; Buccheri D; Cortese B
    Int J Cardiol; 2016 Jan; 203():551-2. PubMed ID: 26569361
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiographically minimal but functionally significant coronary lesion confirmed by optical coherence tomography.
    Yoon HJ; Cho YK; Nam CW; Kim KB; Hur SH
    Korean J Intern Med; 2016 Jul; 31(4):807-8. PubMed ID: 27320616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.